MedPlus profit jumps 46% as pharmacy margins expand
Net profit hit ₹2.20 billion on 12% revenue growth for FY26. The board also shuffled its top ranks.
— 2 earlier stories on Medplus Health Services Ltd. →What's new
- FY26 net profit rose 46.1% to ₹2.20 billion on revenue of ₹68.92 billion.
- The board re-appointed MD G. Madhukar Reddy for another five-year term from August 2026.
- Two new independent directors joined; company secretary Manoj Kumar Srivastava resigned.
Why this matters
The profit growth significantly outpaced revenue growth, signalling a clear improvement in the company's cost structure. This is the financial performance that underpins the board's confidence to lock in the managing director for another five years.
What we're watching
- Whether the improved margins can sustain into FY27.
- The strategy from the two new independent directors.
- The reason for the company secretary's exit and succession plan.
The full read
MedPlus grew revenue 12.3% to ₹68.92 billion in FY26. Net profit surged 46.1% to ₹2.20 billion. The profit line moved almost four times as fast as the top line, a clear signal that the pharmacy chain's costs are under tighter control. That operational strength is the backdrop for the board's concurrent moves: re-instating Managing Director G. Madhukar Reddy for a fresh five-year term and adding two independent directors. The company secretary, Manoj Kumar Srivastava, exited the same day. The results are the strongest yet from the mid-cap retailer, but the real test is whether the margin gains can hold as the chain continues to expand its physical footprint.
Questions answered
- How did MedPlus achieve 46% profit growth on just 12% revenue growth?
- The significant gap indicates the company's costs grew much slower than its sales. The company reported improved operational execution and higher margins on its retail pharmacy sales, which drove a disproportionate jump in profitability.
- What were the key management changes announced?
- The board re-appointed Managing Director G. Madhukar Reddy for a new five-year term starting August 2026. It also appointed two new independent directors to the board.
- Who left the company?
- Manoj Kumar Srivastava, the company secretary, resigned effective May 20, 2026. The filing did not state a reason.
- Is the revenue growth figure for the full year or a quarter?
- The headline figures are for the full fiscal year ended March 2026. The analyst rationale also noted healthy sequential growth in the fourth quarter.
Medplus Health Services Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on MEDPLUS →- 20 May 2026 · 9:18 PM IST MedPlus profit jumps 46% as pharmacy margins expand
- 46d ago MedPlus targets 800 new stores in FY27, private label margins recover
- 47d ago MedPlus profit jumps 46% to ₹2,196.1 mn, revenue up 12% to ₹68,924.6 mn